Just the Facts: Tryptamine Therapeutics' TRP-8803 clears Phase 1b safety trial

By Proactive Investors / October 18, 2024 / www.youtube.com / Article Link


Proactive's Tylah Tully breaks down Just the Facts of the latest news from Tryptamine Therapeutics Ltd (ASX:TYP, OTC:TYPTF).

Recent News

Market still expecting strong growth for major gold producers
July 27, 2026 / www.canadianminingreport.com

Newmont starts Q2/26 strong, growth expected for gold majors
July 27, 2026 / www.canadianminingreport.com

Gold not the consensus play anymore
July 20, 2026 / www.canadianminingreport.com

Gold stocks drop to lowest levels this year
July 20, 2026 / www.canadianminingreport.com

A rebalancing of gold's ratios versus major commodities
July 14, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok